A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.

doi:10.1093/infdis/jix498

Article

A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.

The Journal of infectious diseases - 4 Jan 2018

Novakovic Daniel, Cheng Alan T L, Zurynski Yvonne, Booy Robert, Walker Paul J, Berkowitz Robert, Harrison Henley, Black Robert, Perry Christopher, Vijayasekaran Shyan, Wabnitz David, Burns Hannah, Tabrizi Sepehr N, Garland Suzanne M, Elliott Elizabeth, Brotherton Julia M L

Abstract excerpt

Background: Recurrent respiratory papillomatosis is a rare but morbid disease caused by human papillomavirus (HPV) types 6 and 11. Infection is preventable through HPV vaccination. Following an extensive quadrivalent HPV vaccination program (females 12-26 years in 2007-2009) in Australia, we established a method to monitor incidence and demographics of juvenile-onset recurrent respiratory papillomatosis (JORRP)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.

Abstract excerpt

Topics

Related research